Bausch & Lomb Corp
BLCO · XNYSCIK 1860742fmd_1A38YZ0X6DG423YGD41QCZQJTPManufacturing · Ophthalmic GoodsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 24 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 3,412 | 3,765 | 3,768 | 4,146 | 4,791 | 5,101 |
| Research and development | 253 | 271 | 307 | 324 | 343 | 371 |
| Selling, general and administrative | 1,253 | 1,389 | 1,478 | 1,736 | 2,082 | 2,234 |
| Operating income | 260 | 329 | 207 | 130 | 162 | 113 |
| Interest expense | 0 | 0 | 146 | 283 | 399 | 421 |
| Interest and investment income | 3 | 0 | 6 | 15 | 15 | 12 |
| Other non-operating income (expense) | (38) | (17) | (13) | (74) | – | – |
| Income before taxes | 290 | 318 | 73 | (166) | (234) | (317) |
| Income tax expense | 307 | 125 | 58 | 82 | 71 | 35 |
| Net income from continuing operations | (17) | 193 | 15 | (248) | (305) | (352) |
| Net income | (18) | 182 | 6 | (260) | (317) | (360) |